×
To start your customized experience click the start button
Customize
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
CURE Communications Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Sarcoma

Allie Strickler
Dimosthenis Andreou, M.D., discussed the Euro-EWING99 trial with CURE.
Shannon Connelly
Immunotherapy's role for treating sarcoma is being cemented as more agents and targets are identified.
Laura Panjwani
Treatment and imaging advancements are drastically changing the landscape of sarcoma care.
A Lartruvo (olaratumab) combination received an accelerated approval from the FDA to treat patients with soft tissue sarcoma.
Staff Writer
A recent trial presented an unexpected survival benefit for patients with high-risk soft tissue sarcoma who were on anthracycline-based neoadjuvant chemotherapy.
Laura Panjwani
Immunotherapy may not end up being as successful in treating sarcoma as it is in other types of cancer, says Katherine Thornton M.D. 
Arlene Weintraub


The 50 cancers under the umbrella of soft tissue sarcoma are marked by genetic chaos, and a growing understanding of these mutations may lead to new treatments. 

Laura Panjwani
Keytruda is showing benefit to some patients with sarcoma, according to interim results from a phase 2 trial. 
Gina Columbus
CURE spoke with Noah Federman about the prevalence and treatment of sarcomas in younger patients. 
Jason M. Broderick
The FDA granted olaratumab a priority review for some people with advanced soft tissue sarcoma (STS). 
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment

Caregiver

Healthcare Professional

Not Applicable